NCT04776135View on ClinicalTrials.gov

Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 26, 2021

Primary Completion Date

April 1, 2021

Study Completion Date

April 16, 2021

Conditions
Healthy Adult Subjects
Interventions
DRUG

MT-1186

Suspension

Trial Locations (1)

171-0014

Investigational site, Tokyo

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY